Sign in

CIK 0001158780

  • Non-accelerated filer
  • Smaller reporting company
Ticker
PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
980351734
Phone
+972 747107171
Business address
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
Former names
PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
  1. 4 Grant or award Director acquired 35,000 shares (grant or award)
  2. 4 Grant or award CEO & Co. Chairman acquired 140,000 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 5,500 shares (grant or award)
  13. 4 Grant or award Director acquired 5,500 shares (grant or award)
  14. 4 Grant or award Director acquired 5,500 shares (grant or award)
  15. 4 Grant or award Director acquired 5,500 shares (grant or award)
  16. 4 Grant or award CEO & Co. Chairman acquired 138,536 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 45,000 shares (grant or award)
  18. 4 Grant or award Director acquired 37,500 shares (grant or award)
  19. 4 Grant or award Director acquired 5,500 shares (grant or award)
  20. 4 Open-market buy Director bought 2,500 shares at $1.98 ($4,950)

Page 15 of 18 · 352 filings